PRTN3 and arthritic joint disease: A large cohort study demonstrated that in the preclinical arthritis and non-arthritis groups, compared to ACPA-negative individuals, ACPA-positive individuals exhibited higher levels of TC, TC/HDL, TG, Apo B, and cardiovascular risk index, but lower levels of HDL (22, 172).